The AAP Issued Its Own RSV and COVID Guidance for This Winter. Here's What It Says.

On 2 September 2026, the American Academy of Pediatrics published updated policy statements on RSV and COVID-19 prevention for children — its own recommendations, released ahead of the 2026–27 respiratory season.

If you have a baby, two things about that sentence are unusual, and both are worth understanding before your next appointment.

The first is the timing: RSV season runs roughly October to March, so this guidance lands right at the front of it. The second is more awkward. The AAP’s recommendations and the current federal list are not the same, which means parents are being handed two answers to the same question for the first time in most of our lifetimes.

This page explains what the guidance actually says and where the disagreement comes from. It is not medical advice, and it is not an argument for or against anything. Your pediatrician knows your child; a blog does not.

What the AAP is recommending

For COVID-19: a 2026–27 vaccine for all infants and children aged 6 through 23 months, and a single dose for children and adolescents aged 2 to 18 who are at increased risk — including those living with someone at high risk.

For RSV: protection for infants through two routes that work together rather than competing:

• Maternal vaccination during pregnancy, which passes antibodies to the baby before birth, and
• Monoclonal antibody products for infants under 8 months who did not receive that protection in pregnancy, plus high-risk toddlers roughly 8 to 19 months.

The monoclonal antibody is worth explaining because it confuses people, and the confusion is understandable. It is not a vaccine. A vaccine teaches the immune system to make its own antibodies, which takes time a newborn does not have. A monoclonal antibody is the antibody itself, given directly — protection that works immediately and then fades, rather than protection the body learns to make.

That distinction matters for a baby facing their first winter, because immediate is the entire point.

Why there are two different lists

This is the part that has left parents unsettled, and it deserves a plain explanation rather than a dramatic one.

Federal vaccine recommendations normally come through the CDC’s Advisory Committee on Immunization Practices — ACIP. That committee is currently in legal limbo: a federal judge ruled in March that the Health Secretary unlawfully altered vaccine policy and improperly reconstituted the group. There is no ACIP meeting scheduled this autumn.

With the usual process stalled, professional medical societies stepped in to fill the gap. The AAP published its own schedule; the American Academy of Family Physicians did the same. The AAP’s 2026 childhood schedule covers 18 diseases; the current federal list covers 11.

So the divergence is not two groups of scientists reading the same evidence differently. It is one process working normally and another one interrupted.

The question you are actually asking: is it still covered?

Almost certainly, and this is the most practical thing on this page.

Private insurers have confirmed these vaccines will be covered without cost sharing, and the federal Vaccines for Children programme — which covers children who are uninsured, Medicaid-eligible, or American Indian/Alaska Native — continues to provide access.

One honest caveat: the detailed mechanics of how coverage is administered when AAP and federal guidance diverge are not fully spelled out anywhere public yet. If your child falls into a group the AAP recommends and the federal list does not, ask your pediatrician’s office to confirm coverage before the appointment rather than after. It is a two-minute phone call and it removes the only real uncertainty here.

Timing, practically

RSV protection is aimed at the season, roughly October to March. For a baby born just before or during that window, the timing conversation should happen at the birth or the first well visit — not in January.

COVID timing is more flexible. Where a child has had a recent infection, waiting four to six months is generally preferred.

If you are pregnant now, the maternal RSV vaccination question belongs in your next prenatal appointment, because it is the route that protects the baby from day one.

What to do with all this

Bring it up rather than deciding alone. Your pediatrician is already working from the AAP guidance — it is their professional body. You are not introducing a novel idea by asking about it.

Ask about your specific child, not the category. Prematurity, chronic conditions, and who else lives in the house all change the answer, which is exactly why the recommendations have “high-risk” branches rather than one rule.

Confirm coverage in advance if your child sits in a gap between the two lists.

Do not try to adjudicate the dispute yourself. It is genuinely confusing right now, and the confusion is procedural rather than scientific. The person to resolve it for your family is the one who has your child’s chart open.

A note on how this site handles this

We report what published guidance says, name the source and the date, and show where sources disagree instead of quietly picking one. That is the same standard applied to the AAP’s 2026 iron guidance and to the CDC removing crawling from its milestone list.

Guidance in this area is moving faster than usual in 2026. This page reflects what was published as of 5 September 2026 and will be updated if the position changes.

Educational information only, not medical advice. Immunization decisions belong with your child’s doctor, who knows their history and your circumstances.